Results

Conclusion
Methods
Objective Background
• Abnormal anatomy, sympathetic denervation, rejection, infection, and immunosuppressive drugs may increase the risk for arrhythmias in heart transplanted (HT) patients. • Data are limited regarding arrhythmias in hospitalized HT patients.
• To identify various arrhythmias identified and documented in hospitalized HT patients using a large US national database.
• Nationwide Inpatient Sample databases from 2003 through 2012 were queried for hospitalizations in HT recipient patients ≥ 18 years of age using ICD9 code V42.1 • Hospitalizations with a primary or secondary discharge diagnosis of acute myocardial infarction were excluded. • Individual arrhythmias and associated discharge diagnoses were then identified using appropriate ICD-9 and CCS codes.
• Among hospitalizations in which an arrhythmia was present in a HT patient, the primary discharge diagnosis was more likely to be an infectious disease (21%), rather than the arrhythmia (13%) or congestive heart failure (5.5%; Figure 1B ). •
In patients primarily admitted with complications of the transplanted heart including rejection and allograft vasculopathy (n=443), 24.7% had a diagnosis of an arrhythmia, with almost half having AF (11%).
Results
• Of the 132,552 hospitalizations in HT patients, a diagnosis of arrhythmia was present in in 17,693 (13.3%). • Atrial arrhythmias (7.8%) were substantially more common than ventricular arrhythmias (1.0%). Atrial fibrillation (AF) (6.0%) was the most common arrhythmia followed by atrial flutter (1.8%; Figure 1A ).
• Arrhythmias are common in hospitalized HT patients, with AF being the most common. In this patient population, arrhythmias may often represent a consequence of HT-related complications such as infection or rejection. • Given the anatomical and functional alterations of the transplanted heart, studies are needed to better understand and manage these arrhythmias.
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